PaclitaxelHypersensitivity following off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1910卷 / 1期

关键词：

D O I：

10.1007/s40278-022-17220-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：385 / 385

相关论文

共 50 条

[11] GadobutrolNeurotoxicity following an off label use: case report
Reactions Weekly, 2019, 1773 (1) : 169 - 169
[12] RituximabHypogammaglobulinaemia following off label use: case report
Reactions Weekly, 2023, 1963 (1) : 461 - 461
[13] CidofovirTubulopathy following off label use: case report
Reactions Weekly, 2018, 1731 (1) : 81 - 81
[14] LomitapideDiarrhoea following off label use: case report
Reactions Weekly, 2019, 1763 (1) : 214 - 214
[15] RituximabPneumonia following off label use: case report
Reactions Weekly, 2019, 1779 (1) : 207 - 207
[16] IbrutinibFatigue following off label use: case report
Reactions Weekly, 2019, 1766 (1) : 157 - 157
[17] LiothyronineThyrotoxicosis following off label use: case report
Reactions Weekly, 2022, 1913 (1) : 276 - 276
[18] ErdafitinibRetinopathy following off label use: case report
Reactions Weekly, 2021, 1839 (1) : 132 - 132
[19] KetamineHypertension following off label use: case report
Reactions Weekly, 2020, 1818 (1) : 160 - 160
[20] FluoxetineAkathisia following off label use: case report
Reactions Weekly, 2020, 1811 (1) : 130 - 130

← 1 2 3 4 5 →